relatlimab,nivolumab
bms
['nivo', 'neopredict', 'nivolumab', 'relatlimab', 'nsclc', 'lung', 'sclc', 'lcsm,(-blcsm)']
neopredict-lung: neoadjuvant nivolumab (pd-1) and relatlimab (lag-3). another promising target in the io-io combination. feasible in patients with resectable nsclc. comparable efficacy in early observation. looking forward to checking longer follow-up. #lcsm #esmo22 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC